Aspirin for the next generation

ecancermedicalscience

Volumn 7, Issue 1, 2013, Pages

  Henderson, Nick ^a   Smith, Tom ^b  

^a Aspirin Foundation   (United Kingdom)

^b The Croft   (United Kingdom)

Author keywords

Aspirin; Cancer; Dementia; Diabetes; Hughes syndrome

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 1; HEPARIN; PLACEBO; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROTON PUMP INHIBITOR; ROFECOXIB;

ALZHEIMER DISEASE; ANALGESIC ACTIVITY; ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTIPHOSPHOLIPID SYNDROME; ANTIPYRETIC ACTIVITY; APOPTOSIS; ARTERIOVENOUS FISTULA; ARTERY DISEASE; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BREAST CANCER; CANCER GROWTH; CANCER SUSCEPTIBILITY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; COLON CANCER; COLONOSCOPY; COLORECTAL CANCER; DEEP VEIN THROMBOSIS; DEMENTIA; DIABETES MELLITUS; DRUG ACTIVITY; DRUG MECHANISM; DRUG SAFETY; ELDERLY CARE; ESOPHAGUS CANCER; FUNDING; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HELLP SYNDROME; HEMOSTASIS; HUMAN; LOW DRUG DOSE; MEDICAL RESEARCH; MEDICAL SOCIETY; MULTIINFARCT DEMENTIA; PEPTIC ULCER; PHYSICIAN; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY; PROSTATE CANCER; STOMACH CANCER; TREATMENT CONTRAINDICATION; ULCER; VASCULAR DISEASE; WORLD HEALTH ORGANIZATION;

EID: 84876401207     PISSN: None     EISSN: 17546605     Source Type: Journal    
DOI: 10.3332/ecancer.2013.300     Document Type: Article

References (11)

1. Lynch HT, Lynch JF and Shaw TG (2011) Hereditary gastrointestinal cancer syndromes Gastrointest Cancer Res. 4 (4 Suppl 1): S9-S17 PMID: 22368732 PMCID: PMC3283002
2. http://www.aspree.org/AUS/aspree-content/aspree-study-details/ about-aspree.aspx
3. Hart J, Hawkey CJ, Lanas A, Naesdal J, Talley NJ, Thomson ABR and Yeomans ND(2010) Predictors of gastroduodenal erosions in patients taking low-dose aspirin Aliment Pharmacol & Ther. 31(1) 143-149 DOI: 10.1111/j.1365-2036. 2009.04133.x PMCID: 3597726
4. http://clinicaltrials.gov/ct2/show/NCT01506986
5. Meyer JS, Rogers RL, McClintic K, Mortel KF and Lotfi J (1989) Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study J Am Geriatr Soc. 37 (6) 549-55 PMID: 2654259
6. Richards M, Meade TW, Peart S, Brennan PJ and Mann AH (1997) Is there any evidence for a protective effect of antithrombotic medication on cognitive function in men at risk of cardiovascular disease? Some preliminary findings. Neurol Neurosurg Psychiatry 62 (3) 269-72 PMID: 9069483 PMCID: PMC1064157
7. Devine ME and Rands G (2003) Does aspirin affect outcome in vascular dementia? A retrospective case-notes analysis Int. J Geriatric Psychiatry 18 (5) 425-431 DOI: 10.1002/gps.857
8. Baigent C, Collins R, Appleby P, Parish S, Sleight P and Peto R (1998) ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither BMJ 316 (7141): 1337-1343 DOI: 10.1136/bmj.316.7141.1337 PMID: 9563981
9. Antithrombotic Trialists' Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 (7329): 71-86 PMID: 11786451 PMCID: 64503
10. Rothwell PM, Price JF, Fowkes FG, Zanchetti A, Roncaglioni MC, Tognoni G, Lee R, Belch JF, Wilson M, Mehta Z and Meade TW (2012) Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials Lancet 379 (9826):1602-12 DOI: 10.1016/S0140-6736(11)61720-0 PMID: 22440946
11. McQuaid KR and Laine L (2006) Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials Am J Med 119 624-638 DOI: 10.1016/j.amjmed.2005.10.039 PMID: 16887404